Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Picci

Showing results (211-220 of 289) with videos related to

Pageof 29
Sort By:
Cancer Research|September 29, 1998
Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic miceK Scotlandi, S Benini, P Nanni, et al.
Tumori|June 30, 1992
Osteosarcoma of the extremity metastatic at presentation: results achieved in 26 patients treated with combined therapy (primary chemotherapy followed by simultaneous resection of the primary and metastatic lesions)G Bacci, P Picci, A Briccoli, et al.
Human Pathology|April 1, 1996
Immunostaining of the p30/32MIC2 antigen and molecular detection of EWS rearrangements for the diagnosis of Ewing's sarcoma and peripheral neuroectodermal tumorK Scotlandi, M Serra, M C Manara, et al.
La Chirurgia Degli Organi Di Movimento|January 1, 1991
Neoadjuvant chemotherapy for the treatment of osteosarcoma of the limbs. Preliminary results in 100 patients treated preoperatively with high doses of methotrexate i.v. followed by cisplatin (i.a.) and adriamycinG Bacci, P Picci, P Ruggieri, et al.
Pediatric Blood & Cancer|January 15, 2009
Response to high-dose ifosfamide in patients with advanced/recurrent Ewing sarcomaS Ferrari, A Brach del Prever, E Palmerini, et al.
Tumori|August 31, 1989
Giant cell tumor of bone: a model for the in vitro human osteoclast characterizationM Campanacci, G P Bagnara, M Serra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing's sarcoma cellsS Benini, M C Manara, N Baldini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2000
Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated reportG Bacci, S Ferrari, F Bertoni, et al.
La Chirurgia Degli Organi Di Movimento|January 1, 1995
Neoadjuvant chemotherapy for the treatment of osteosarcoma of the extremities: excellent response of the primary tumor to preoperative treatment with methotrexate, cisplatin, adriamycin, and ifosfamide. Preliminary resultsG Bacci, P Picci, S Ferrari, et al.
Journal of Chemotherapy (Florence, Italy)|June 1, 1992
Effect of intra-arterial versus intravenous cisplatin in addition to systemic adriamycin and high-dose methotrexate on histologic tumor response of osteosarcoma of the extremitiesG Bacci, P Picci, M Avella, et al.
Pageof 29

Showing results (211-220 of 289) with videos related to

Sort By:
Pageof 29
Cancer Research|September 29, 1998
Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic miceK Scotlandi, S Benini, P Nanni, et al.
Tumori|June 30, 1992
Osteosarcoma of the extremity metastatic at presentation: results achieved in 26 patients treated with combined therapy (primary chemotherapy followed by simultaneous resection of the primary and metastatic lesions)G Bacci, P Picci, A Briccoli, et al.
Human Pathology|April 1, 1996
Immunostaining of the p30/32MIC2 antigen and molecular detection of EWS rearrangements for the diagnosis of Ewing's sarcoma and peripheral neuroectodermal tumorK Scotlandi, M Serra, M C Manara, et al.
La Chirurgia Degli Organi Di Movimento|January 1, 1991
Neoadjuvant chemotherapy for the treatment of osteosarcoma of the limbs. Preliminary results in 100 patients treated preoperatively with high doses of methotrexate i.v. followed by cisplatin (i.a.) and adriamycinG Bacci, P Picci, P Ruggieri, et al.
Pediatric Blood & Cancer|January 15, 2009
Response to high-dose ifosfamide in patients with advanced/recurrent Ewing sarcomaS Ferrari, A Brach del Prever, E Palmerini, et al.
Tumori|August 31, 1989
Giant cell tumor of bone: a model for the in vitro human osteoclast characterizationM Campanacci, G P Bagnara, M Serra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing's sarcoma cellsS Benini, M C Manara, N Baldini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2000
Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated reportG Bacci, S Ferrari, F Bertoni, et al.
La Chirurgia Degli Organi Di Movimento|January 1, 1995
Neoadjuvant chemotherapy for the treatment of osteosarcoma of the extremities: excellent response of the primary tumor to preoperative treatment with methotrexate, cisplatin, adriamycin, and ifosfamide. Preliminary resultsG Bacci, P Picci, S Ferrari, et al.
Journal of Chemotherapy (Florence, Italy)|June 1, 1992
Effect of intra-arterial versus intravenous cisplatin in addition to systemic adriamycin and high-dose methotrexate on histologic tumor response of osteosarcoma of the extremitiesG Bacci, P Picci, M Avella, et al.
Pageof 29